tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ANTX Stock Latest News

AN2 Therapeutics upgraded to Outperform from Market Perform at JMP Securities
The FlyAN2 Therapeutics upgraded to Outperform from Market Perform at JMP Securities
1M ago
ANTX
AN2 Therapeutics’ High-Stakes Gamble: Navigating FDA Approval for Epetraborole Amid Clinical Trial Uncertainties
PremiumCompany Announcements
AN2 Therapeutics’ High-Stakes Gamble: Navigating FDA Approval for Epetraborole Amid Clinical Trial Uncertainties
1M ago
ANTX
AN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
PremiumThe Fly
AN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
1M ago
ANTX
ANTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ANTX Earnings this Week: How Will it Perform?
1M ago
ANTX
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
2M ago
ANTX
INSM
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe FlyCantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
2M ago
ANTX
INSM
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
2M ago
ANTX
INSM
SHAREHOLDER ALERT: Potential Recovery for AN2 Therapeutics, Inc. (ANTX) Investors
PremiumClass Action
SHAREHOLDER ALERT: Potential Recovery for AN2 Therapeutics, Inc. (ANTX) Investors
2M ago
ANTX
AN2 Therapeutics Inc trading resumes
PremiumThe Fly
AN2 Therapeutics Inc trading resumes
3M ago
ANTX
AN2 Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
AN2 Therapeutics Inc trading halted, volatility trading pause
3M ago
ANTX
AN2 Therapeutics downgraded on efficacy questions at Leerink
PremiumThe Fly
AN2 Therapeutics downgraded on efficacy questions at Leerink
3M ago
ANTX
AN2 Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
AN2 Therapeutics downgraded to Market Perform from Outperform at Leerink
3M ago
ANTX
AN2 Therapeutics downgraded to In Line from Outperform at Evercore ISI
PremiumThe FlyAN2 Therapeutics downgraded to In Line from Outperform at Evercore ISI
3M ago
ANTX
AN2 Therapeutics downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
AN2 Therapeutics downgraded to Perform from Outperform at Oppenheimer
3M ago
ANTX
AN2 Therapeutics downgraded to Market Perform from Outperform at JMP Securities
PremiumThe Fly
AN2 Therapeutics downgraded to Market Perform from Outperform at JMP Securities
3M ago
ANTX
AN2 Therapeutics Reassesses Phase 3 Trial Amid Efficacy Concerns
PremiumCompany Announcements
AN2 Therapeutics Reassesses Phase 3 Trial Amid Efficacy Concerns
3M ago
8K
ANTX
AN2 Therapeutics Reviews Epetraborole Phase 3 Trial Enrollment
PremiumCompany Announcements
AN2 Therapeutics Reviews Epetraborole Phase 3 Trial Enrollment
3M ago
8K
ANTX
AN2 Therapeutics Reviews Phase 2 Data, Pauses Phase 3 Trial Enrollment
PremiumCompany Announcements
AN2 Therapeutics Reviews Phase 2 Data, Pauses Phase 3 Trial Enrollment
3M ago
8K
ANTX
AN2 Therapeutics pausing enrollment in Phase 2 trial of epetraborole
PremiumThe Fly
AN2 Therapeutics pausing enrollment in Phase 2 trial of epetraborole
3M ago
ANTX
AN2 Therapeutics initiated with an Outperform at JMP Securities
PremiumThe FlyAN2 Therapeutics initiated with an Outperform at JMP Securities
4M ago
ANTX
AN2 Therapeutics price target raised to $28 from $27 at Oppenheimer
PremiumThe Fly
AN2 Therapeutics price target raised to $28 from $27 at Oppenheimer
6M ago
ANTX
AN2 Therapeutics reports Q3 net loss ($16.7M) vs. ($11.3M) last year
PremiumThe Fly
AN2 Therapeutics reports Q3 net loss ($16.7M) vs. ($11.3M) last year
6M ago
ANTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >